We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

34 hedge funds and large institutions have $110K invested in CERo Therapeutics Warrants in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

8% less funds holding

Funds holding: 37 → 34 (-3)

74% less capital invested

Capital invested by funds: $425K → $110K (-$315K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
34
Holders Change
-3
Holders Change %
-8.11%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
5
Closed
4
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$7.77K
2
Walleye Trading
Walleye Trading
New York
+$4.37K
3
CAC
Cowen and Company
New York
+$2.84K
4
CS
Clear Street
New York
+$70
5
Bank of America
Bank of America
North Carolina
+$29

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$9.6K
2
ICM
Ionic Capital Management
New York
-$5.48K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.24K
4
WAM
Wolverine Asset Management
Illinois
-$1.19K
5
FTUS
Flow Traders U.S.
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$16.6K – – –
CAC
2
Cowen and Company
New York
$13.8K +$2.84K +48,467 +8%
CF
3
Cantor Fitzgerald
New York
$8.87K – – –
PC
4
Periscope Capital
Ontario, Canada
$8.6K -$9.6K -163,866 -28%
ACM
5
Atalaya Capital Management
New York
$8.5K -$8 -133 -0%
MI
6
MMCAP International
Cayman Islands
$7.54K – – –
SCM
7
Saba Capital Management
New York
$5.95K – – –
LA
8
Linden Advisors
New York
$5.63K – – –
CSD
9
Clear Street Derivatives
New York
$5.39K – – –
SCM
10
Shaolin Capital Management
Florida
$5.38K – – –
Walleye Capital
11
Walleye Capital
New York
$3.15K +$7.77K +132,608 +553%
QGA
12
Q Global Advisors
Texas
$3K – – –
CS
13
Clear Street
New York
$2.92K +$70 +1,200 +0.8%
CCM
14
Context Capital Management
California
$2.45K – – –
NAM
15
Nexpoint Asset Management
Texas
$2.19K – – –
Walleye Trading
16
Walleye Trading
New York
$1.77K +$4.37K +74,592 +553%
WCMNY
17
Westchester Capital Management (New York)
New York
$1.5K – – –
YCM
18
Yakira Capital Management
Connecticut
$1.01K – – –
KL
19
KIM LLC
Kansas
$1K – – –
TCM
20
Tenor Capital Management
New York
$1K – – –
PMAM
21
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
WAM
22
Wolverine Asset Management
Illinois
$880 -$1.19K -20,317 -32%
WA
23
Whitebox Advisors
Minnesota
$503 – – –
RCM
24
Rivernorth Capital Management
Florida
$500 – – –
SSA
25
Schonfeld Strategic Advisors
New York
$301 -$293 -5,000 -25%
1
2

CEROW Hedge Fund Activity: Q2 2024 in Review

34 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q2 2024, worth a combined $110K — down 74% from $425K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CEROW and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 5 added.

The largest buyer was Walleye Capital, adding an estimated $7.77K. The largest seller was Periscope Capital, cutting an estimated $9.6K.

  • 34 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q2 2024, down from 37 in Q1 2024.
  • Funds reported $110K of CERo Therapeutics Warrants stock for Q2 2024, down 74% quarter-over-quarter.
  • 1 fund opened new CERo Therapeutics Warrants positions in Q2 2024 and 4 closed out, a net change of -3 holders.
  • The largest CERo Therapeutics Warrants buyer in Q2 2024 was Walleye Capital, an estimated $7.77K added.
  • The largest CERo Therapeutics Warrants seller in Q2 2024 was Periscope Capital, an estimated $9.6K sold.

Based on aggregated 13F filings for Q2 2024.